Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-08

Clinical Trial Update: of Myo-inositol, Melatonin and Co-enzyme q10 on Ovarian Reserve [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating whether myo-inositol, melatonin, and CoQ10 affect ovarian reserve in women undergoing IVF (NCT06405204).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Coenzyme Q10 (Coenzyme Q10)
  • Melatonin (melatonin)
  • Myo-inositol (myo-inositol)

Snippet

Sponsor: Beni-Suef University | Conditions: IVF | Phase 3 | Status: NOT_YET_RECRUITING